Abstract
To evaluate the safety and efficacy of three doses of PF-04523655, a 19-nucleotide methylated double stranded siRNA targeting the RTP801 gene, for the treatment of diabetic macular edema (DME) compared to focal/grid laser photocoagulation.
| Original language | English |
|---|---|
| Journal | Investigative ophthalmology & visual science |
| Volume | 53 |
| Issue number | 12 |
| Pages (from-to) | 7666-74 |
| Number of pages | 9 |
| ISSN | 0146-0404 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Diabetic Retinopathy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Macula Lutea
- Macular Edema
- Male
- Middle Aged
- Prospective Studies
- RNA, Small Interfering
- Tomography, Optical Coherence
- Treatment Outcome
- Visual Acuity
Fingerprint
Dive into the research topics of 'Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS